Human medicines European public assessment report (EPAR): Ximluci, ranibizumab, Date of authorisation: 09/11/2022, Revision: 2, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 March 2024 - 13:46

Human medicines European public assessment report (EPAR): Ximluci, ranibizumab, Date of authorisation: 09/11/2022, Revision: 2, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/ximluci

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters